Analysts Set Align Technology, Inc. (NASDAQ:ALGN) Price Target at $175.45

Shares of Align Technology, Inc. (NASDAQ:ALGN) have earned an average recommendation of “Hold” from the sixteen analysts that are covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, seven have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $175.4545.

A number of equities analysts have recently weighed in on ALGN shares. Morgan Stanley upped their target price on Align Technology from $142.00 to $154.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. Needham & Company LLC reaffirmed a “hold” rating on shares of Align Technology in a research report on Thursday, October 30th. Jefferies Financial Group upped their price objective on shares of Align Technology from $140.00 to $155.00 in a research note on Thursday, October 30th. Wall Street Zen raised shares of Align Technology from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Finally, Wells Fargo & Company cut their price objective on Align Technology from $199.00 to $181.00 and set an “overweight” rating for the company in a report on Thursday, October 30th.

Hedge Funds Weigh In On Align Technology

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ALGN. Redmond Asset Management LLC increased its stake in shares of Align Technology by 2.0% during the 1st quarter. Redmond Asset Management LLC now owns 2,769 shares of the medical equipment provider’s stock worth $440,000 after purchasing an additional 54 shares during the last quarter. Horizon Investments LLC lifted its stake in shares of Align Technology by 6.2% in the 1st quarter. Horizon Investments LLC now owns 1,018 shares of the medical equipment provider’s stock valued at $162,000 after purchasing an additional 59 shares during the last quarter. Atria Investments Inc boosted its holdings in Align Technology by 4.9% in the second quarter. Atria Investments Inc now owns 1,575 shares of the medical equipment provider’s stock worth $298,000 after purchasing an additional 74 shares in the last quarter. IFP Advisors Inc increased its position in Align Technology by 5.7% during the second quarter. IFP Advisors Inc now owns 1,427 shares of the medical equipment provider’s stock worth $270,000 after buying an additional 77 shares during the last quarter. Finally, Covestor Ltd increased its position in Align Technology by 18.8% during the first quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock worth $78,000 after buying an additional 78 shares during the last quarter. Institutional investors own 88.43% of the company’s stock.

Align Technology Stock Down 3.3%

Shares of NASDAQ:ALGN opened at $132.61 on Friday. The company’s fifty day moving average is $132.83 and its two-hundred day moving average is $158.73. The company has a market cap of $9.51 billion, a P/E ratio of 25.70, a price-to-earnings-growth ratio of 1.49 and a beta of 1.84. Align Technology has a 12-month low of $122.00 and a 12-month high of $246.19.

Align Technology (NASDAQ:ALGN) last issued its earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 EPS for the quarter, topping the consensus estimate of $2.38 by $0.23. The business had revenue of $995.69 million during the quarter, compared to analysts’ expectations of $980.75 million. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.Align Technology’s revenue was up 1.8% compared to the same quarter last year. During the same quarter last year, the firm posted $2.35 earnings per share. Align Technology has set its Q4 2025 guidance at EPS. Equities research analysts anticipate that Align Technology will post 7.98 earnings per share for the current year.

Align Technology announced that its board has authorized a share buyback program on Tuesday, August 5th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to repurchase up to 2% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board of directors believes its shares are undervalued.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.